Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
5.79
+0.25 (4.51%)
At close: Jun 27, 2025, 4:00 PM
5.82
+0.03 (0.52%)
After-hours: Jun 27, 2025, 6:19 PM EDT
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $273.46 million as of June 27, 2025. Its market cap has decreased by -71.86% in one year.
Market Cap
273.46M
Enterprise Value
136.99M
1-Year Change
-71.86%
Ranking
Category
Stock Price
$5.79
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from $538.37M to $273.46M, a decrease of -49.21%. That is a compound annual growth rate of -13.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 273.46M | -15.82% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | 610.91M | 13.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 708.31B |
| Johnson & Johnson | 366.28B |
| AbbVie | 328.14B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 276.26B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 233.82B |
| AstraZeneca | 215.99B |